In a report released on July 13, David S Macdonald from Truist Financial maintained a Buy rating on Cigna (CI – Research Report). The company’s shares closed last Friday at $282.76. S Macdonald covers the Healthcare sector, focusing on stocks such as Amedisys, UnitedHealth, and Option Care Health. According to TipRanks, S Macdonald has an average return of 12.1% and a 63.34% success rate on recommended stocks.  Currently, the analyst consensus on Cigna is a Moderate Buy with an average price target of $318.93, representing a 12.79% upside. In a report released on July 13, UBS also maintained a Buy rating on the stock with a $355.00 price target. See the top stocks recommended by analysts >> The company has a one-year high of $337.07  and a one-year low of $239.37. Currently, Cigna has an average volume of 1.66M.
		  TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Founded in 1792, Cigna Corporation is a Connecticut-based global health services company, which provides insurance and related products and services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other.  Read More on CI: Indices Commodities Currencies Stocks